Related Experiment Video
Updated: Aug 8, 2026
IP-FCM: Immunoprecipitation Detected by Flow Cytometry
Published on: December 2, 2010
A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry
C C Chang1, B C Schur, B Kampalath
1Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. jeffchang@pol.net
Insights
A novel flow cytometry method accurately detects cytoplasmic immunoglobulin light chain expression, identifying minute clonal lymphocyte populations in multiple myeloma (MM) patients. This discovery may offer significant prognostic value for MM patient outcomes.
Area of Science:
- Immunology
- Hematology
- Flow Cytometry
Background:
- Accurate detection of cytoplasmic immunoglobulin light chain (LC) expression is crucial for diagnosing and monitoring plasma cell dyscrasias like multiple myeloma (MM).
- Existing methods may have limitations in sensitivity for detecting small or aberrant cell populations.
Purpose of the Study:
- To develop and validate a novel, highly sensitive two-step flow cytometric approach for quantifying cytoplasmic LC expression.
- To investigate the presence and potential prognostic significance of minute clonal lymphocyte populations in MM patients.
Main Methods:
- A lysed-whole-blood technique followed by two-step flow cytometry acquisition.
- Incubation with CD38 and CD45 antibodies, followed by permeabilization and staining for kappa or lambda LC.
- Analysis involved gating on CD38 expression and evaluating shifts in FITC fluorescence intensity to detect cytoplasmic LC.
Main Results:
- The novel method successfully identified cytoplasmic LC expression, distinguishing clonal plasma cells (CD38 bright) in 13 of 15 MM patients.
- A minute clonal lymphocyte population (CD38 dim, CD45 bright) with identical LC restriction was detected in 12 of 13 MM patients.
- A lower ratio of minor clonal population to clonal plasma cells (<0.07) correlated with better remission status (4/5 vs. 1/4).
Conclusions:
- The described two-step flow cytometry technique is highly sensitive for detecting cytoplasmic LC and minute clonal lymphocyte populations in MM.
- The presence and ratio of these minute clonal lymphocyte populations may hold significant prognostic value in multiple myeloma.
- Further studies are warranted to confirm the prognostic implications of these findings in a larger patient cohort.
Abstract:
We describe a novel flow cytometric approach using a two-step acquisition technique to determine the cytoplasmic immunoglobulin light chains (LC) expression. Samples were prepared by a lysed-whole-blood technique and incubated with CD38-PE (phycoerythrin) and CD45-FITC (fluorescein isothiocyanate). The cells were fixed and acquired on an FACSCalibur flow cytometer (first acquisition). The cells were then permeabilized, incubated with either kappa-FITC or lambda-FITC and reacquired (second acquisition). Analysis of the data was performed by gating on the differing intensities of CD38 and evaluating them for the presence of a shifting FITC-positive population from the first acquisition to the second acquisition. The FITC fluorescence intensity of the second acquisition was equal to the sum of surface CD45 expression obtained during the first acquisition and the cytoplasmic LC expression obtained during the second acquisition. Thus, the shifting (increase) of FITC fluorescence intensity during the second acquisition is specifically due to the cytoplasmic expression of either the kappa or lambda LC. We studied 15 multiple myeloma (MM) patients and 10 controls (samples from patients without plasma cell dyscrasias). None of the controls showed evidence of any clonal populations. Thirteen of 15 MM patients exhibited clonal plasma cells (CD38 bright), ranging from 0.01% to 34% of total events collected. In addition, we identified another minute clonal population of lymphocytes (CD38 dim, CD45 bright, low forward and side scatter) in 12 of 13 MM patients with clonal plasma cells. This population, ranging from 0.01% to 0.6% of total events collected, had the same LC restriction as the clonal plasma cells. Patients with a ratio of minor clonal population to clonal plasma cells less than 0.07 tended to remain in partial or complete remission than those with a ratio > or =0.07 (4/5 versus 1/4, P <.1, chi(2)). We conclude that this method is highly sensitive and permits us to identify the minute clonal population of lymphocytes in MM patients. Our preliminary observations with a small cohort of patients imply that this minute clonal population may have important prognostic significance. The prognostic significance should be confirmed by further studies.
